Codone Biotechnology
PrivateCompany Overview
Codone Biotechnology is a biotechnology company that develops transformative medicines based on suppressor-tRNAs for patients with severe diseases caused by premature termination codons.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
gene therapysuppressor-tRNAnonsense mutationsAAV deliverygenetic medicineadeno-associated virusAAVbiotech platformdrug discoveryprotein translationgenetic diseasepreclinical researchtherapeutic screeningrare disease therapybiotech startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codone Biotechnology Comparables
Compare Codone Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alltrna | 87% | |
| Tevard Biosciences | 86% | |
| Shape Therapeutics | 74% | |
Codone Biotechnology Funding Rounds
Historical fundraising activity
Codone Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Codone Biotechnology's valuation, stock price, and market status.
See something wrong or outdated?